Adherence, Persistence, and Effectiveness in Real Life. Multicenter Long-Term Study on the Use of Pirfenidone and Nintedanib in the Treatment of Idiopathic Pulmonary Fibrosis.

Fiorenzo SantoleriLuigia AuriemmaAntonella SpaconeStefano MarinariFabio EspositoFrancesco De VitaGiovanni PetragnaniCaterina Di FabioLetizia Di FabioAlberto Costantini

Published in: Journal of pharmacy practice (2021)

The stratification of the adherence values as a function of the response to treatment in terms of FVC at 12 months for both study drugs showed that patients with optimal response scored adherence of more than 90%.

Keyphrases

idiopathic pulmonary fibrosis
randomized controlled trial
interstitial lung disease
systematic review
type diabetes
combination therapy
clinical trial
glycemic control
metabolic syndrome
skeletal muscle
weight loss
smoking cessation